By: Karen Mandelbaum , RyAnn M. Hooper & Susan Gross Sholinsky EPSTEIN BECKER GREEN, P.C. This article will explore the privacy concerns created when implementing a mandatory vaccine policy and collecting vaccination status information from employees...

By: D. Reed Freeman Jr., ARENTFOX SCHIFF LLP THIS ARTICLE DISCUSSES THE PRINCIPLE OF DATA MINIMIZATION in the context of commercial applications of generative artificial intelligence (GenAI) technology and tools. In the United States, the principle...

By: Romaine Marshall and Jennifer Bauer , Polsinelli PC This article addresses the broad scope of artificial intelligence (AI) laws in the United States that focus on mitigating risk, and discusses the patchwork of laws, regulations, and industry standards...

By: Laura D. Richman and Michael L. Hermsen , Mayer Brown LLP This article discusses some key ramifications of the coronavirus outbreak for public companies. In addition to a host of significant general business concerns, such as those relating to liquidity...

By: Matthew D. Jenkins , Hunton Andrews Kurth LLP This article provides an overview of compliance obligations and federal False Claims Act (FCA) risks to healthcare and life sciences companies arising out of three funding streams made available in response...